Interv Akut Kardiol. 2019;18(1):28-31 | DOI: 10.36290/kar.2018.019

The use of optical coherence tomography in acute coronary syndrome

Tereza Nováková, Petr Kala, Lenka Prýmková, Jan Kaňovský
Interní kardiologická klinika FN a LF MU Brno

Acute coronary syndrome as an acute form of coronary artery disease is one of the most important causes of patient morbidity and mortality. Its most effective treatment method is percutaneous coronary intervention (PCI) routinely using angiographic imaging. Currently, the most accurate assessment of coronary artery morphology is provided by optical coherence tomography (OCT), an intravascular imaging technique. The main application of OCT has been shifting from mostly scientific use to almost routine practice in recent years, particularly in patients with acute coronary syndrome. Optical coherence tomography is, except for a few limitations, one of unbeatable imaging methods with respect to image resolution and the amount of information obtained. First data have been available suggesting a patient benefit from the use of OCT in interventional treatment of patients with acute myocardial infarction. The paper provides an overview of the use of OCT, especially in patients with acute coronary syndrome.

Keywords: optical coherence tomography, acute coronary syndrome, coronary intervention, PCI

Received: September 2, 2018; Accepted: September 4, 2018; Published: March 8, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nováková T, Kala P, Prýmková L, Kaňovský J. The use of optical coherence tomography in acute coronary syndrome. Interv Akut Kardiol. 2019;18(1):28-31. doi: 10.36290/kar.2018.019.
Download citation

References

  1. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009; 2(11): 1035-1046. Go to original source... Go to PubMed...
  2. Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010; 31(4): 401-415. Go to original source... Go to PubMed...
  3. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336(18): 1276-1282. Go to original source...
  4. Prati F, Uemura S, Souteyrand G, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC: Cardiovascular Imaging 2013; 6(3): 283-287. Go to original source... Go to PubMed...
  5. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39(2): 119-177. Go to original source...
  6. Bělohlávek J. Doporučený postup pro diagnostiku a léčbu akutních koronárních syndromů bez elevací ST úseků na EKG. Vnitřní Lékařství 2008; 54(Suppl. 1): 1S7-23.
  7. Ferrante G, Presbitero P, Whitbourn R, Barlis P. Current applications of optical coherence tomography for coronary intervention. International Journal of Cardiology 2012. Go to original source...
  8. Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. Journal of the American College of Cardiology 2013; 62(19): 1748-1758. Go to original source... Go to PubMed...
  9. Magro M, Regar E, Gutiérrez-Chico JL, et al. Residual atherothrombotic material after stenting in acute myocardial infarction - an optical coherence tomographic evaluation. International Journal of Cardiology 2013; 167(3): 656-663. Go to original source...
  10. Cervinka P, Spaček R, Bystroň M, et al. Optical coherence tomography-guided primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: a pilot study. Can J Cardiol 2014; 30(4): 420-427. Go to original source...
  11. Ikenaga H, Ishihara M, Inoue I, et al. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Cardiol 2013; 62(2): 71-76. Go to original source...
  12. Kocka V, Maly M, Tousek P, et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study "Prague 19". Eur Heart J 2014. Go to original source...
  13. Guagliumi G, Capodanno D, Saia F, et al. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv 2014; 7(9): 958-968. Go to original source... Go to PubMed...
  14. Kala P, Cervinka P, Jakl M, et al. OCT guidance during stent implantation in primary PCI: A randomized multicenter study with nine months of optical coherence tomography follow-up. Int J Cardiol 2018; 250: 98-103. Go to original source...
  15. Azzalini L, Mitomo S, Hachinohe D, Regazzoli D, Colombo A, et al. Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography. Can J Cardiol. 2018; 34(3) 342-342. Go to original source...
  16. ILUMIEN IV: OPTIMAL PCI - Full Text View - ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT03507777. Accessed July 24, 2018.
  17. Liu L, Gardecki JA, Nadkarni SK, et al. Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med 2011; 17(8): 1010-1014. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.